期刊文献+

高效液相色谱法测定癫痫患者血浆中拉莫三嗪的浓度 被引量:7

Determination of plasma concentration of lamotrigine in epilepsy patients by RP-HPLC
原文传递
导出
摘要 目的:建立测定血浆中拉莫三嗪浓度的高效液相色谱方法。方法:以氯唑沙宗为内标,血浆样品用乙醚萃取,采用C18柱(4.6mm×250mm,5μm)分析。流动相为乙腈-0.05mol·L-1磷酸二氢钠溶液(v/v,26.5∶73.5,pH 4.5),流速为1.0mL.min-1,检测波长220nm,柱温25℃。结果:拉莫三嗪浓度在0.5~30μg·mL-1范围内线性关系良好,r=0.9911,定量下限为0.5μg·mL-1,提取回收率在90.00%~93.75%,日内、日间RSD均<15%。25例癫痫患者拉莫三嗪血药浓度范围为0.5~10.2μg·mL-1,与推荐的拉莫三嗪有效治疗浓度相比波动较大,标准化血药浓度为0.8~5.1μg·mL-1,拉莫三嗪血药浓度与日剂量(0.5~3.8mg.kg-1.d-1)线性相关。结论:该方法简便、准确、灵敏度高、回收率及精密度高,可用于拉莫三嗪的血药浓度监测。 OBJECFIVE To develop an HPLC method for the determination of lamotrigine in human plasma. METHODS With chlorzoxazone as internal standard, the plasma was extracted with diethyl ether. The analysis was conducted on a C18 column. The flow rate was 1.0 mL·min^-1 and the column temperature was 25 ℃. The detecting wavelength was set at 220 nm. The mobile phase consisted of acetonitrile-0. 05 mot·L^-1 biphosphate sodium(v/v,26. 5:73. 5,pH 4. 5). RESULTS The linear range of lamotrigine was 0.5~30 μg·mL^-1 (r = 0. 991 1 ) and the detection limit was 0. 5μg·mL^-1 . The range of extraction recovery ratio was 90. 00% - 93.75%. The intra-and inter-day precision was both less than 15%. The concentration range of lamotrigine in 25 epilepsy patients was 0. 5 - 10. 2μg·mL^-1 , which fluctuated more widely compared with the recommended concentration. The relationship between lamotrigine plasma concentration and daily doses (0. 5 - 3.8 mg·kg^-1·d^-1 ) was linear.concentration. The relationship between lamotrigine plasma concentration and daily doses (0. 5 - 3.8 mg·kg^-1·d^-1 ) was linear. The range of the lamotrigine concentration to dose ratio was 0. 8 - 5.1 μg·mL^-1. CONCLUSION The method is simple, accurate, sensitive, which is suitable for the study of therapeutic drug concentration monitoring of lamotrigine.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第7期552-555,共4页 Chinese Journal of Hospital Pharmacy
基金 辽宁省科学技术计划项目(编号:2009225020)
关键词 拉莫三嗪 反相高效液相色谱法 血药浓度 lamotrigine RP-HPLC plasma concentration
  • 相关文献

参考文献17

  • 1Hirsch LJ, Weintraub D, Du Y, et al. Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy [J]. Neurology, 2004, 63 : 1022-1026.
  • 2Bartoli A, Guerrini R, Belmonte A, et al. The influence of dosage, age, and comedication on steady state plasma lam- otrigine concentrations in epileptic children: a prospective study with preliminary assessment of correlations with clinical response[J]. Ther Drug Monit,1997,19 (3) : 252-260.
  • 3Pellock JM. The clinical efficacy of lamotrigine as an antiepi- leptic drug[J]. Neurology, 1994, 44(11, Suppl. 8):29-35.
  • 4Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy [J]. Lancet,1995, 345(8948): 476-479.
  • 5May TW, Rambeck B, Jurgens U. Serum concentrations of lamotrigine in epileptic patients: the influence of dose and co- medication[J]. Ther Drug Monit, 1996, 18:523-531.
  • 6Gidal BE, Anderson GD, Lanning A, et cd. Lack of effect of VPA concentration on lamotrigine pharrnacokinetics in devel opmentally disabled patients with epilepsy[J]. Epilepsy Res, 2000,42 ( 1 ) : 23-31.
  • 7陈小陆,任斌,肖力,王振宁,陈洁,冀满丰,李瑞明,陈孝.HPLC测定拉莫三嗪血药浓度[J].中国药学杂志,2008,43(3):232-233. 被引量:14
  • 8李琪,雷力力,张志国,汪凤山.HPLC法测定人血浆中的拉莫三嗪[J].黑龙江医药科学,2011,34(6):39-40. 被引量:4
  • 9杜军,李忆军.RP-HPLC测定拉莫三嗪和苯巴比妥的血药浓度[J].中国医药导报,2010,7(8):39-41. 被引量:6
  • 10钱方,王玉亮,刘皋林,邓渝林,包军.RP-HPLC法测定拉莫三嗪的血药浓度及应用[J].第二军医大学学报,2000,21(10):998-999. 被引量:6

二级参考文献32

共引文献26

同被引文献66

  • 1Shen CH,Zhang YX,Lu RY,Jin B,Wang S,Liu ZR,Tang YL,丁美萍.OCT1和ABCG2基因多态性与中国癫痫患者拉莫三嗪血药浓度相关性研究[J].癫痫杂志,2016,2(6):555-556. 被引量:8
  • 2廖卫平,宋志彬,杨少青,蒲蜀湘,易咏红,赵绮华.拉莫三嗪治疗癫癎的有效性与剂量、血药浓度及合并用药关系的研究[J].中国神经精神疾病杂志,2005,31(6):438-441. 被引量:28
  • 3Majkowski J, Bourgeois B, Patsalos P, et al. Antiepileptic drugs combination therapy and interactions [M]. New York: Cambridge University Press, 2005 : 393.
  • 4Serralheiro A, Alves G, Fortuna A, et al. First HPLC-UV method for rapid and simultaneous quantification of phenobar- bital, primidone, phenytoin, carbamazepine, carbamazepi- ne-10, ll-epoxide, 10, ll-trans-dihydroxy-10, ll-dihydro- carbamazepine, lamotrigine, oxcarbazepine and licarbazepine in human plasma [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2013, 925: 1-9.
  • 5Hotha KK, Kumar SS, Bharathi DV, et al. Rapid and sen- sitive LC-MS/MS method for quantification of lamotrigine in human plasma: application to a human pharmacokinetic study [J]. Biomed Chromatogr, 2012, 26 (4) : 491-496.
  • 6Shah H J, Subbaiah G, Patel DM, et al. Rapid quantification of lamotrigine in human plasma by two LC systems connected with tandem MS [J]. J Chromatogr Sci, 2010, 48 ( 5 ) : 375-381.
  • 7Lee W, Kim JH, Kim HS, et al. Determination of lamotri- gine in human serum by high-performance liquid chromatogra- phy-tandem mass spectrometry [J]. Neurol Sci, 2010, 31 ( 6 ) : 717-720.
  • 8Bialer M, White HS. Key factors in the discovery and deve- lopment of new antiepileptic drugs [J]. Nat Rev Drug Discov,2010, 9 (1) : 68-82.
  • 9Brunetto Mdel R, Contreras Y, Delgado Y, et al. Develop- ment and validation of a rapid column-switching high-perfor- mance liquid chromatographic method for the determination of Lamotrigine in human serum [J]. J Chromatogr Sci, 2009, 47 (6) : 478-484.
  • 10Vermeij TA, Edelbroek PM. Robust isocratic high perfor- mance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamot- rigine, oxcarbazepine and zonisamide in serum after solid- phase extraction [J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2007, 857 ( 1 ) : 40-46.

引证文献7

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部